source
- HHS nominee Chris Klomp faces questioning from Sen. Elizabeth Warren on voluntary drug‑pricing contractsDeputy Secretary of Health and Human Services nominee Chris Klomp testified before the Senate Finance Committee on September 15, 2026. The hearing was described as relatively mild overall. During…
- Rocket Pharmaceuticals aligns with FDA on Danon therapy as Novo exits Ascendis and Lilly announces new dealRocket Pharmaceuticals said it has reached alignment with the U.S. FDA regarding its commercial-stage program for Danon disease, indicating the agency and the company are on the same page about the…